Scientists summarize the reprogramming of fibroblasts into induced pluripotent stem cell-derived cardiomyocytes, induced cardiac progenitor cells, and induced cardiomyocytes to repair a damaged heart, outline recent findings in utilizing fibroblast-derived cells for heart regeneration, and discuss the limitations and challenges.
[Journal of Molecular and Cellular Cardiology]